Impact of CA9 expression in the diagnosis of lymph-node metastases in non-small cell lung cancer based on [18F]FDG PET/CT
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0312846 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Satoshi Suzuki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Fluorodeoxyglucose F18, Lung Neoplasms, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lung cancer is the leading cause of the global cancer incidence and mortality. It is important to obtain an accurate diagnosis of lymph-node metastasis before surgery to select the therapeutic strategy for non-small cell lung cancer (NSCLC) patients. Carbonic anhydrase 9 (CA9) is considered a marker of hypoxia and it has reported that CA9 is associated with tumor invasion and metastasis. In this study, the correlation between the CA9 expression for lymph-node metastases in NSCLC and [ 18 F]FDG PET/CT results was investigated in order to clarify the efficacy of [ 18 F]FDG PET/CT for detecting lymph-node metastases of NSCLC patients.
Methods
Among the 564 patients who underwent surgical treatment for NSCLC between 2010 and 2016 at our hospital, a total of 338 patients who underwent preoperative [ 18 F]FDG PET/CT were included in this study. CA9 expression was evaluated by immunochemistry. A lymph node with maximum standardized uptake value (SUVmax) ≥2.5 on [ 18 F]FDG PET/CT was preoperatively defined as a metastatic lymph node.
Result
CA9 positivity was detected in 122 patients; the other 216 patients were CA9-negative. The CA9-positive NSCLC cases significantly associated with pleural invasion ( p = 0.0063), pT-factor ( p = 0.0080), pN-factor ( p = 0.036) and pStage ( p = 0.043). CA9-positive patients presented significantly poorer survival rate for OS than that of the CA9-negative patients ( p = 0.0024). In the multivariable analysis, histological SCC and CA9 positivity were independent poor-prognosis factors for OS. For the total patient population, the sensitivity and specificity of [ 18 F]FDG PET/CT for lymph-node metastases were 54% and 89%, respectively. In contrast, the sensitivity and specificity were particularly low in the CA9-positive SCC cases (36% and 69%, respectively). Conclusion [ 18 F]FDG PET/CT might not be useful for diagnosing lymph-node metastases of CA9-positive SCC cases of NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
- Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
- Department of Thoracic Surgery, Kansai Rosai Hospital, Hyogo, Japan.
ORCID-Profile: Masakazu Yashiro
Zitieren
APA
Suzuki, S., Yashiro, M., Izumi, N., Tsukioka, T., Inoue, H., Hara, K., Ito, R., Tanimura, T., & Nishiyama, N. (2024). Impact of CA9 expression in the diagnosis of lymph-node metastases in non-small cell lung cancer based on [18F]FDG PET/CT. PLOS ONE. https://doi.org/10.1371/journal.pone.0312846
Vancouver
Suzuki S, Yashiro M, Izumi N, Tsukioka T, Inoue H, Hara K, et al. Impact of CA9 expression in the diagnosis of lymph-node metastases in non-small cell lung cancer based on [18F]FDG PET/CT. PLOS ONE. 2024. doi:10.1371/journal.pone.0312846
BibTeX
@article{Suzuki2024,
author = {Suzuki, Satoshi and Yashiro, Masakazu and Izumi, Nobuhiro and Tsukioka, Takuma and Inoue, Hidetoshi and Hara, Kantaro and Ito, Ryuichi and Tanimura, Takuya and Nishiyama, Noritoshi},
title = {Impact of CA9 expression in the diagnosis of lymph-node metastases in non-small cell lung cancer based on [18F]FDG PET/CT},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0312846}
}
EUVIMED